1. Home
  2. BRCC vs ACRS Comparison

BRCC vs ACRS Comparison

Compare BRCC & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRCC
  • ACRS
  • Stock Information
  • Founded
  • BRCC 2014
  • ACRS 2012
  • Country
  • BRCC United States
  • ACRS United States
  • Employees
  • BRCC N/A
  • ACRS N/A
  • Industry
  • BRCC Beverages (Production/Distribution)
  • ACRS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BRCC Consumer Staples
  • ACRS Health Care
  • Exchange
  • BRCC Nasdaq
  • ACRS Nasdaq
  • Market Cap
  • BRCC 186.6M
  • ACRS 198.2M
  • IPO Year
  • BRCC N/A
  • ACRS 2015
  • Fundamental
  • Price
  • BRCC $1.34
  • ACRS $2.38
  • Analyst Decision
  • BRCC Strong Buy
  • ACRS Strong Buy
  • Analyst Count
  • BRCC 4
  • ACRS 9
  • Target Price
  • BRCC $2.75
  • ACRS $9.25
  • AVG Volume (30 Days)
  • BRCC 486.3K
  • ACRS 1.3M
  • Earning Date
  • BRCC 11-03-2025
  • ACRS 11-06-2025
  • Dividend Yield
  • BRCC N/A
  • ACRS N/A
  • EPS Growth
  • BRCC N/A
  • ACRS N/A
  • EPS
  • BRCC N/A
  • ACRS N/A
  • Revenue
  • BRCC $388,893,000.00
  • ACRS $16,789,000.00
  • Revenue This Year
  • BRCC $3.98
  • ACRS N/A
  • Revenue Next Year
  • BRCC $12.08
  • ACRS N/A
  • P/E Ratio
  • BRCC N/A
  • ACRS N/A
  • Revenue Growth
  • BRCC N/A
  • ACRS N/A
  • 52 Week Low
  • BRCC $1.19
  • ACRS $1.05
  • 52 Week High
  • BRCC $3.52
  • ACRS $5.17
  • Technical
  • Relative Strength Index (RSI)
  • BRCC 38.46
  • ACRS 64.87
  • Support Level
  • BRCC $1.33
  • ACRS $2.10
  • Resistance Level
  • BRCC $1.43
  • ACRS $2.47
  • Average True Range (ATR)
  • BRCC 0.05
  • ACRS 0.18
  • MACD
  • BRCC 0.00
  • ACRS 0.04
  • Stochastic Oscillator
  • BRCC 26.80
  • ACRS 85.06

About BRCC BRC Inc.

BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. It is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. Its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

Share on Social Networks: